search
Back to results

A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer

Primary Purpose

Diabetic Foot Ulcer

Status
Unknown status
Phase
Phase 1
Locations
China
Study Type
Interventional
Intervention
Standardized Western Medicine Treatment
Tangningtongluo tablet and cream
Tangningtongluo tablet
Tangningtongluo cream
Sponsored by
Affiliated Hospital of Nantong University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Diabetic Foot Ulcer

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Clinical diagnosis of Type 2 diabetes mellitus
  • Clinical diagnosis of Diabetic Foot Ulcer

Exclusion Criteria:

  • Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia
  • TNTL allergy
  • Chronic kidney failure(eGFR≤30ml/min/1.73cm2), severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors
  • Recent acute complications of type 2 diabetes mellitus(ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.)or other emergency situations
  • History of using glucocorticoids and immunosuppressants
  • Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required
  • Malignant ulcer

Sites / Locations

  • Gu YunjuanRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Experimental

Experimental

Experimental

Arm Label

Standardized Western Medicine Treatment Group

Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group

Standardized Western Medicine Treatment +TNTL tablet Group

Standardized Western Medicine Treatment +TNTL cream Group

Arm Description

All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).

Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.

Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.

Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.

Outcomes

Primary Outcome Measures

Decrease area of wound healing due to Diabetic Foot Ulcer
Assessment the decrease of whole area of diabetic foot ulcers. The unit is square centimeters .
Decrease of depth of ulcer involve the deep fascia.
Measurement of depth of ulcer involve the deep fascia. The unit is millimeters.
Amputation Rate
The difference of end-stage amputation rates between the experimental group and the control group were evaluated by the arterial and venous blood circulation of the lower limbs
Diabetic Foot Ulcer relapse rate
The relapse of Diabetic Foot Ulcers is a common complication in the advanced stage of DFU. The difference of treatment between the experimental group and the control group indicates that the prognosis is variability.

Secondary Outcome Measures

Fasting glucose
10 hours after fasting peripheral blood glucose level, and the unit is mmol/L
2-H postload glucose
2 hours after peripheral blood glucose level eating 75g glucose or 100g steamed bread, and the unit is mmol/L
BMI Index
The calculation formula of Body Mass Index is: BMI = weight ÷ height 2. (weight in kilograms; height in meters.)
WHR Index
Waist to hip ratio (WHR) = waist / hip.Waist circumference or minimum waist circumference shall be used for measurement, and evaluation of WHR is an important value to central obesity.
Islet B cell function
The ability of islet B cells to secrete insulin was reflected by the level of C peptide, which is measured after fasting. The unit is ng/dL .
interleukin-6(IL-6)
Determine the level of interleukin-6(IL-6) in peripheral blood by ELISA, the unit is ng/L.
tumour necrosis factor-α(TNF-α)
Determine the level of TNF-α in peripheral blood , the unit is ng/ml.
C-reactive protein(CRP)
Determine the level of C-reactive protein(CRP) in peripheral blood , the unit is μg/L.

Full Information

First Posted
September 2, 2021
Last Updated
March 4, 2022
Sponsor
Affiliated Hospital of Nantong University
search

1. Study Identification

Unique Protocol Identification Number
NCT05145140
Brief Title
A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Official Title
A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer
Study Type
Interventional

2. Study Status

Record Verification Date
September 2021
Overall Recruitment Status
Unknown status
Study Start Date
January 15, 2022 (Actual)
Primary Completion Date
December 30, 2022 (Anticipated)
Study Completion Date
March 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Affiliated Hospital of Nantong University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Purpose and significance:With the increasing incidence of Diabetes mellitus (DM), the incidence rate of Diabetic Foot (DF) is raised. DF is a foot infection, ulceration and / or deep tissue destruction caused by nerve abnormalities and varying degrees of vascular lesions in DM patients. The high incidence, disability and mortality rate of DF make it urgent to explore new ways to improve the cure rate, reduce the burden and elevate the quality of life. Previous studies have confirmed that traditional Miao ethic medicine Tangningtongluo(TNTL) can improve the remission rate of diabetes mellitus and diabetic foot disease, but the clinical research evidence is not sufficient. This study aims to provide effective clinical evidence for the treatment of diabetic foot patients with TNTL by observing growth rate of wound, prognosis and outcome. Methods: From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed. Type of study: randomized controlled, prospective,intervention study.
Detailed Description
From September 2021 to March 2023, a total of 80 diabetic foot ulcer patients admitted to Department of Endocrinology and Metabolism at the Affiliated Hospital of Nantong University were recruited. Participants are randomized in a ratio of 1: 1: 1:1 into four treatment groups of 20 participants: (i) standardized western medicine treatment group, (ii) standardized western medicine treatment+TNTL tablet+TNTL cream group , (iii) standardized western medicine treatment+TNTL tablet group, and (iiii) standardized western medicine treatment+TNTL cream group. Treatment with TNTL tablets: the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing. Anthropometric parameters, serum biochemical index, glycosylated hemoglobin, urinary microalbumin/creatinine ratio, islet-specific autoantibodies(ISAs), fat mass, and islet β-cell function were measured. The healing stage of the wound surface and the growth degree of granulation tissue were graded, and the time required for wound repairing to each healing stage was observed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcer

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 1
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
80 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Standardized Western Medicine Treatment Group
Arm Type
Active Comparator
Arm Description
All participants undergo a similar treatment protocol for the diabetic foot, based on the Infectious Diseases Society of America (IDSA).
Arm Title
Standardized Western Medicine Treatment +TNTL tablet+TNTL cream Group
Arm Type
Experimental
Arm Description
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day. Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
Arm Title
Standardized Western Medicine Treatment +TNTL tablet Group
Arm Type
Experimental
Arm Description
Treatment with TNTL tablets:the oral administration of TNTL tablets, 4 tablets each time, 3 times a day.
Arm Title
Standardized Western Medicine Treatment +TNTL cream Group
Arm Type
Experimental
Arm Description
Treatment with TNTL cream: topical application of sterile TNTL cream on the wound surface, the dressing is continuously changed according to the wound healing.
Intervention Type
Drug
Intervention Name(s)
Standardized Western Medicine Treatment
Other Intervention Name(s)
Classic Diabetic Foot Ulcer treatment
Intervention Description
Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Intervention Type
Drug
Intervention Name(s)
Tangningtongluo tablet and cream
Other Intervention Name(s)
Tangningtongluo Pian and Tangningtongluo Gao
Intervention Description
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.There are two dosage forms: tablet and cream.
Intervention Type
Drug
Intervention Name(s)
Tangningtongluo tablet
Other Intervention Name(s)
Tangningtongluo Pian
Intervention Description
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use tablet.
Intervention Type
Drug
Intervention Name(s)
Tangningtongluo cream
Other Intervention Name(s)
Tangningtongluo Gao
Intervention Description
Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use cream.
Primary Outcome Measure Information:
Title
Decrease area of wound healing due to Diabetic Foot Ulcer
Description
Assessment the decrease of whole area of diabetic foot ulcers. The unit is square centimeters .
Time Frame
12 weeks
Title
Decrease of depth of ulcer involve the deep fascia.
Description
Measurement of depth of ulcer involve the deep fascia. The unit is millimeters.
Time Frame
12 weeks
Title
Amputation Rate
Description
The difference of end-stage amputation rates between the experimental group and the control group were evaluated by the arterial and venous blood circulation of the lower limbs
Time Frame
12 weeks
Title
Diabetic Foot Ulcer relapse rate
Description
The relapse of Diabetic Foot Ulcers is a common complication in the advanced stage of DFU. The difference of treatment between the experimental group and the control group indicates that the prognosis is variability.
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Fasting glucose
Description
10 hours after fasting peripheral blood glucose level, and the unit is mmol/L
Time Frame
12 weeks
Title
2-H postload glucose
Description
2 hours after peripheral blood glucose level eating 75g glucose or 100g steamed bread, and the unit is mmol/L
Time Frame
12 weeks
Title
BMI Index
Description
The calculation formula of Body Mass Index is: BMI = weight ÷ height 2. (weight in kilograms; height in meters.)
Time Frame
12 weeks
Title
WHR Index
Description
Waist to hip ratio (WHR) = waist / hip.Waist circumference or minimum waist circumference shall be used for measurement, and evaluation of WHR is an important value to central obesity.
Time Frame
12 weeks
Title
Islet B cell function
Description
The ability of islet B cells to secrete insulin was reflected by the level of C peptide, which is measured after fasting. The unit is ng/dL .
Time Frame
12 weeks
Title
interleukin-6(IL-6)
Description
Determine the level of interleukin-6(IL-6) in peripheral blood by ELISA, the unit is ng/L.
Time Frame
12 weeks
Title
tumour necrosis factor-α(TNF-α)
Description
Determine the level of TNF-α in peripheral blood , the unit is ng/ml.
Time Frame
12 weeks
Title
C-reactive protein(CRP)
Description
Determine the level of C-reactive protein(CRP) in peripheral blood , the unit is μg/L.
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Clinical diagnosis of Type 2 diabetes mellitus Clinical diagnosis of Diabetic Foot Ulcer Exclusion Criteria: Type 1 diabetes mellitus(T1DM), special type of diabetes, gestational diabetes mellitus, drug-induced hyperglycemia TNTL allergy Chronic kidney failure(eGFR≤30ml/min/1.73cm2), severe liver function damage (transaminase ≥ 3 times the normal value), acute or chronic pancreatitis, autoimmune disease, malignant tumors Recent acute complications of type 2 diabetes mellitus(ketoacidosis, hyperosmolar nonketotic diabetic coma, lactic acidosis etc.)or other emergency situations History of using glucocorticoids and immunosuppressants Mental illness and cognitive dysfunction or poor compliance, unable to take medication as required Malignant ulcer
Facility Information:
Facility Name
Gu Yunjuan
City
Nantong
State/Province
Jiangsu
ZIP/Postal Code
226001
Country
China
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Gu Yunjuan, M.D/Ph.D
Phone
+8615851207860
Email
desette@ntu.edu.cn

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Clinical Intervention Study of Tangningtongluo on Diabetic Foot Ulcer

We'll reach out to this number within 24 hrs